We are live on
!
Find out more
Xenon Pharmaceuticals
XENE
XENE
246 hedge funds and large institutions have $3.78B invested in Xenon Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 81 increasing their positions, 74 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
132% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 22
12% more funds holding
Funds holding: 219 → 246 (+27)
12% more capital invested
Capital invested by funds: $3.39B → $3.78B (+$399M)
9% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 74
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
0.06% less ownership
Funds ownership: 109.36% → 109.29% (-0.06%)
34% less call options, than puts
Call options by funds: $36.4M | Put options by funds: $54.7M
Holders
246
Holders Change
+27
Holders Change %
+12.33%
% of All Funds
2.99%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
51
Increased
81
Reduced
74
Closed
22
Calls
$36.4M
Puts
$54.7M
Net Calls
-$18.4M
Net Calls Change
-$14.5M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$48.5M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$34.5M |
| 3 |
Barclays
London,
United Kingdom
|
+$20.6M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$18.5M |
| 5 |
Two Sigma Investments
New York
|
+$18.3M |
Top Sellers
| 1 |
B
Braidwell
Stamford,
Connecticut
|
-$74.8M |
| 2 |
CC
Commodore Capital
New York
|
-$37.8M |
| 3 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$35M |
| 4 |
Millennium Management
New York
|
-$31.5M |
| 5 |
Holocene Advisors
New York
|
-$29.2M |
